Since APPswe/PS1dE9 mice display significant age-related attenuation of cholinergic neurotransmission in the cortex and hippocampus between 7 and 17 months of age21, we expected cholinesterase inhibitors to yield a similar effect in this specific AD model. The gene discussed is BCHE; the disease is Alzheimer disease.